However, the BRCA and HNSC (including oral cancer and nasopharyngeal cancer) didn’t show significant alterations in AKR1B10 expression, which suggests the analysis with a refined cancer subtype may be helpful to clarify the AKR1B10 expression in special pathological conditions. This evidence concerns the gene AKR1B10 and cancer.